Home » Authors » Trista Morrison

Articles by Trista Morrison

Roche Ends 10-Year Court Fight By Acquiring BioVeris For $600M

April 5, 2007

By Trista Morrison

Syndax Gets $40M Series A To Build Cancer Combo Pipeline

April 4, 2007

By Trista Morrison

Syndax Gets $40M Series A To Build Cancer Combo Pipeline

April 4, 2007

By Trista Morrison

Roche Acquires Therapeutic Human Polyclonals For $56.5M

April 3, 2007

By Trista Morrison

Roche Acquires Therapeutic Human Polyclonals For $56.5M

April 3, 2007

By Trista Morrison

Vivus Gets Up To $180M From KV Pharma For Hot Flash Drug

April 2, 2007

By Trista Morrison

FDA Wants Another Phase III For NeoPharm's GBM Drug

March 30, 2007

By Trista Morrison

FDA Wants Another Phase III For NeoPharm's GBM Drug

March 30, 2007

By Trista Morrison

Samaritan, Pharmaplaz Partner On Phase II HIV Drug SP-01A

March 29, 2007

By Trista Morrison

Samaritan, Pharmaplaz Partner On Phase II HIV Drug SP-01A

March 29, 2007

By Trista Morrison

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...